Treatment of immune-mediated diseases by oral administration...

Details Treatment of immune-mediated diseases by oral administration... Treatment of immune-mediated diseases by oral administration...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 19/02 (2006.01) A61P 37/02 (2006.01) A61K 38/12 (2006.01)

Patent

CA 2423805

Human plasma fractions such as Cohn Fraction II + III, may be administered orally to patients suffering from a myriad of immune-mediated diseases, including rheumatoid arthritis, to treat the disease conditions of those patients.

Pour traiter des patients souffrant d'une des très nombreuses maladies d'origine immunitaire, y compris l'arthrite rhumatoïde, on peut administrer à ces deniers, par voie orale, des fractions de plasma humain sensiblement enrichies en immunoglobuline humaine G, telle que la fraction Cohn II + III et facultativement un antiacide. L'administration par voie orale de la fraction Cohn II + III produit une amélioration clinique significative du degré de l'activité de la maladie chez les patients souffrant d'arthrite rhumatoïde par exemple.

Affiliated with

Also associated with

Rating

Treatment of immune-mediated diseases by oral administration... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of immune-mediated diseases by oral administration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of immune-mediated diseases by oral administration... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1655992